Rare diseases
Investigational molecules
Locations
Study on the Effects of Upadacitinib in Adults and Adolescents with Non-Segmental Vitiligo Eligible for Systemic Treatment
ItalyStudy of Oral Ozanimod as Maintenance Treatment for Adults with Moderate to Severe Crohn's Disease
ItalyStudy on the Effectiveness of Povorcitinib for Adults with Nonsegmental Vitiligo
ItalyStudy on the Effects of Human Normal Immunoglobulin in Adults with Dermatomyositis
ItalyStudy on the Long-Term Safety and Efficacy of Oral Ozanimod for Patients with Moderate to Severe Crohn's Disease
ItalyStudy of inclisiran to prevent heart attacks and strokes in people with atherosclerotic cardiovascular disease
ItalyStudy of anifrolumab effectiveness compared to placebo in adults aged 18-70 with systemic sclerosis
ItalyStudy of RVU120 for Patients with Relapsed or Refractory High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia
ItalyStudy on BI 685509 for Adults with Systemic Sclerosis to Assess Effects on Lung Function and Symptoms
ItalyStudy on the Long-Term Safety and Effectiveness of Minzasolmin and Iodine Ioflupane (123I) in Patients with Parkinson's Disease
ItalyStudy on Inclisiran for Preventing Heart Disease in High-Risk Patients
ItalyWeight loss in adults with obesity (with or without type 2 diabetes) using cagrilintide and semaglutide: a study of two dose levels versus semaglutide alone
ItalyTell us about your condition – we search every trial in Europe and connect you with the right site.
